These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21593176)

  • 21. Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases.
    Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2007 Feb; 81(3):1313-8. PubMed ID: 17108042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model.
    Watts AM; Bright RK; Kennedy RC
    Dev Biol (Basel); 2000; 104():143-7. PubMed ID: 11713812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expression.
    Bright RK; Shearer MH; Kennedy RC
    Cancer Immunol Immunother; 1993 Jul; 37(1):31-9. PubMed ID: 7685654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice.
    Mauch C; Grimm C; Meckel S; Wands JR; Blum HE; Roggendorf M; Geissler M
    Vaccine; 2001 Oct; 20(1-2):170-80. PubMed ID: 11567762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes.
    Cai MS; Deng SX; Li ML
    Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T cell responses to endogenously presented HLA-A*0201 restricted peptides of Simian virus 40 large T antigen.
    Velders MP; Macedo MF; Provenzano M; Elmishad AG; Holzhütter HG; Carbone M; Kast WM
    J Cell Biochem; 2001 Apr 2-27; 82(1):155-62. PubMed ID: 11400172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
    Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
    J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).
    Tevethia SS; Flyer DC; Tjian R
    Virology; 1980 Nov; 107(1):13-23. PubMed ID: 6255675
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
    Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
    Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of simian virus 40 exposure in a colony of captive baboons.
    Westfall LW; Shearer MH; Jumper CA; White GL; Papin JF; Eberle R; Butel JS; Bright RK; Kennedy RC
    Virology; 2008 Jul; 377(1):54-62. PubMed ID: 18485439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.
    Lowe DB; Shearer MH; Aldrich JF; Winn RE; Jumper CA; Kennedy RC
    J Virol; 2010 Oct; 84(19):10121-30. PubMed ID: 20668083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses.
    Bråve A; Nyström S; Roos AK; Applequist SE
    Immunol Cell Biol; 2011 Mar; 89(3):492-6. PubMed ID: 20838412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.